American Society of Addiciton Medicine

Board of Directors

Leadership

Board of Directors

Anika Alvanzo, MD, MS, FACP, DFASAM

Secretary


Anika Alvanzo, MD, MS, FACP, DFASAM is a graduate of the George Washington University School of Medicine and Health Sciences, holds a master’s degree in biostatistics from Virginia Commonwealth University, and is board certified in Internal Medicine and Addiction Medicine. Dr. Alvanzo is the Managing Partner of Uzima Consulting Group, LLC, which provides addiction-related consultation, training, and expert witness testimony and a physician consultant to the Behavioral Health Administration in the Maryland Department of Health. She is a Distinguished Fellow of ASAM, a Past President of the Maryland-DC Society of Addiction Medicine, and currently serves as Chair of the ASAM Annual Conference Program Planning Committee and Secretary for the ASAM Board of Directors. 

Dr. Alvanzo has over 15 years of experience in the field of Addiction Medicine. She was previously the Eastern Region Medical Director for Pyramid Healthcare, Inc overseeing medical treatment in residential and outpatient addiction treatment programs in Eastern Pennsylvania and Maryland. Prior to this, Dr. Alvanzo spent twelve years as faculty in the Divisions of General Internal Medicine and Addiction Medicine at Johns Hopkins University School of Medicine where she held a variety of clinical leadership roles, including Associate Medical Director and Medical Director of the comprehensive, opioid treatment programs on the Johns Hopkins Bayview Medical and Johns Hopkins Hospital campuses, respectively, and director of the multidisciplinary inpatient addiction consultation service serving the Johns Hopkins Hospital Department of Medicine. In addition to her clinical work, Dr. Alvanzo has served as an expert on National Institutes of Health, Substance Abuse and Mental Health Services Administration, National Academies of Sciences, Engineering and Medicine, National Quality Forum, and PEW Research Center panels regarding opioids and integration of recovery-oriented care in various settings.